Screener
Tyra Biosciences, Inc. TYRA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other income: | ||
| Interest and other income, net | 2,693 | 3,703 |
| Total other income | 2,693 | 3,703 |
| Net loss | (39,305) | (28,147) |
| Unrealized loss on marketable securities, net | (286) | (82) |
| Comprehensive loss | $(39,591) | $(28,229) |
| Net loss per share, basic and diluted | $(0.64) | $(0.47) |
| Weighted-average shares used to compute net loss per share, basic and diluted | 61,746,050 | 59,336,550 |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s net income?
- Tyra Biosciences, Inc. (TYRA) reported net income of -$39.31M in Q1 2026.
- How has Tyra Biosciences, Inc.'s net income changed year-over-year?
- Tyra Biosciences, Inc.'s net income decreased by 39.6% year-over-year, from -$28.15M to -$39.31M.
- What is the long-term trend for Tyra Biosciences, Inc.'s net income?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s net income has grown at a 46.1% compound annual growth rate (CAGR), from -$26.29M to -$119.95M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Tyra Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude